RMH Holdings Limited

RMH Holdings Limited

8437.HK
RMH Holdings LimitedHK flagHong Kong Stock Exchange
0.25
HKD
+0.01
- -
16.65MMarket Cap
RMH Holdings Limited
8437.HK
(Hong Kong Stock Exchange)

Recent

price

0.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
0.25
0.27
0.29
0.23
0.24
0.26
- -
0.07
0.05
0.08
0.05
Revenue per Share
0.1
0.12
-0.02
0.06
0.01
-0.3
-0.18
-0.29
-0.1
-0.05
-0.11
Basic EPS, GAAP
0.14
0.12
-0.02
0.05
-0.03
-0.22
-0.15
-0.1
0.01
- -
- -
Free Cash Flow per Basic Share
0.13
0.13
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.03
0.02
0.04
0.09
0.1
-0.21
-0.31
-0.5
-0.59
-0.64
-0.64
Book Value per Share
0.03
0.02
0.52
0.48
0.48
0.17
0.08
-0.11
-0.19
-0.37
-0.21
Tangible Book Value per Share
23
23
24
30
30
30
48
65
67
67
62
Basic Weighted Avg Shares
6
6
7
7
7
8
- -
4
3
5
3
Sales/Revenue/Turnover
46.21
49.55
41.11
28.08
2.13
-67.92
-2,592.86
-201.6
-209.53
-59.52
-209.53
Operating Margin (%)
- -
- -
- -
- -
1
3
4
4
2
1
2
Depreciation Expense
2
3
- -
2
- -
-9
-9
-19
-7
-4
-7
Net Income, GAAP
12.72
11.93
- -
13.14
58.31
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
40.23
43.52
-6.66
26.49
2.19
-118.73
-3,691.18
-439.73
-212.23
-69.51
-212.23
Profit Margin (%)
- -
- -
12
14
11
1
3
-7
-12
-22
-12
Working Capital
- -
- -
- -
- -
8
6
7
1
- -
3
- -
LT Debt
1
- -
13
15
15
6
5
-6
-13
-24
-13
Total Equity
- -
188.7
- -
12.12
0.32
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
287.03
- -
96.08
2.34
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
446.83
-65.41
96.08
5.39
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'23
Sep'23
Dec'23
ST Debt
8
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
67
- -
67
Market Capitalization
1
1
1

Working Capital

FRC

in mil. unless spec.
Jun'23
Sep'23
Dec'23
Total Current Assets
6
- -
3
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
5
- -
- -
Inventories
1
- -
1
Total Current Liabilities
16
- -
15
Payables & Accruals
- -
- -
- -
ST Debt
8
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-24.79%
95%
Free Cash Flow
- -
102.31%
-69.29%
Net Income, GAAP
- -
-1,194.64%
-48.05%
Sales/Revenue/Turnover
- -
325.33%
58.62%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
1
1
1
3
2024
- -
- -
- -
- -
5
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.03
- -
- -
- -
-0.1
2024
- -
- -
- -
- -
-0.05
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
RMH Holdings Limited (8437.HK) is a Singapore-based investment holding company that provides specialist medical, dermatological, aesthetic, and dental services through its subsidiaries. The company operates primarily in the healthcare sector across Singapore, Hong Kong, and the People's Republic of China, offering dermatology aesthetic and treatment services for conditions including skin cancer, eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts; dental care and implantation services encompassing orthodontics and implantology; clinical healthcare services such as consultation, prescription, dispensing, diagnostic screening with computed tomography scanners, magnetic resonance imaging, ultrasounds, and mammography; community dermatology for less complicated conditions and non-invasive aesthetic treatments; and trading sales of health and nutritional supplements as well as medical products like hand sanitizers and disposable masks. Incorporated in 2017 as an exempted company in the Cayman Islands and headquartered at #17-01/02 Paragon (Office Tower), 290 Orchard Road, Singapore 238859, RMH Holdings also manages franchised oral and dental clinics and focuses on personalized patient care in its treatment services, trading sales, and dental services segments. In recent developments, the company continues to emphasize its GEM-listed status on the Hong Kong Stock Exchange since 2017 while navigating operational challenges reflected in its latest financial statements, including the release of its 2023 annual report and quarterly results in April 2024 amid a competitive healthcare market.